Diffuse large B-cell lymphoma (DLBCL) is the most commonly-occurring type of non-
Hodgkin lymphoma and is considered a curable disease in at least 50% of patients …

MicroRNAs (miRNAs) are small endogenous RNA molecules that regulate gene expression
at the post-transcriptional level through its sequence complementation with target mRNAs …

MicroRNAs are naturally occurring small RNA species that regulate gene expression and
are frequently abnormally expressed in cancers. However, the role of microRNAs in …

The aberrant expression of microRNAs (miRs) has a significant impact on the biological
characteristics of lymphocytes, and is important in the pathogenesis of diffuse large B‑cell …

Diffuse large B cell lymphoma (DLBCL) is the most common subtype of invasive non-
Hodgkin's lymphoma (NHL). DLBCL presents with variable backgrounds, which results in …

B-cell non-Hodgkin's lymphomas are tumors of B-cells that arise following clonal expansion
and consequent invasion of immune organs by B-cells blocked at a certain step of the …

Molecular biologists have collected considerable data regarding the involvement of genes
and microRNAs (miRNAs) in cancer. However the underlying mechanisms of cancer with …

Despite better therapeutic options and improved survival of diffuse large B-cell lymphoma
(DLBCL), 30–40% of the patients experience relapse or have primary refractory disease with …

Simple Summary Around 30–40% of patients with diffuse large B cell lymphoma suffer early
relapse after standard chemotherapy, but today no prediction whether a patient belongs to …

Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly
40% of all lymphoid tumors. This heterogeneous disease can be divided into germinal …